Form 8-K Teladoc Health, Inc. For: Jan 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Cowen Reiterates Outperform Rating on Teladoc (TDOC) Following Raised Revenue Guidance
January 10, 2022 12:51 PM ESTCowen analyst Charles Rhyee reiterated an Outperform rating and $161.00 price target on Teladoc (NYSE: TDOC) after the company raised its 2021 revenue guidance to $2.03B at an industry conference (vs. prior $2.015B-$2.025B, consensus of $2.02B), and reiterated its prelim 2022 guide of $2.6B.
Rhyee... More
